Healthcare -
Biotechnology - NASDAQ - US
$ 15.04
-3.16 %
$ 1.19 B
Market Cap
-3.48
P/E
VRDN - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities VRDN - Viridian Therapeutics, Inc.
226 M
LAST VALUE
34.22%
2 YEAR CAGR
40.03%
5 YEAR CAGR
68.01%
10 YEAR CAGR